A routine shingles shot may offer powerful defense against dementia

Shingles vaccination is linked to fewer dementia diagnoses and deaths in older adults

A large quasi-experimental study in Wales shows that eligibility for shingles vaccination is linked to fewer new mild cognitive impairment diagnoses and lower dementia-related mortality. Benefits appear strongest in women and are observed at multiple stages of the dementia disease course.

An Existing Vaccine Could Slow Dementia And Cut Death Risk by 30%

A shingles vaccination program that began in Wales in 2013 has led to two discoveries that give fresh hope to efforts to treat dementia: The vaccine appears to reduce the risk of mild cognitive impairment, as well as slowing progression of dementia in those already diagnosed.

Shingles Vaccine Doesn’t Just Lower Dementia Risk, It Could Also Help Treat It

New research finds the shingles vaccine can potentially provide broad protection against dementia.

Shingles Vaccine May Reduce Dementia Risk and Could Slow Disease Progression

An unusual vaccine program in Wales seems to confirm previous suspicions that shingles vaccination protects against dementia.

Lower dementia risk linked to routine vaccination in major new analysis

Stanford Medicine researchers found that older adults who received the shingles vaccine were 20% less likely to develop dementia over the next seven years.

Shingles Vaccine Cuts Dementia Deaths By Half In Women, Study Shows

Formal statistical testing confirmed the difference between women and men was unlikely to be coincidental. The post Shingles Vaccine Cuts Dementia Deaths By Half In Women, Study Shows appeared first on Study Finds.